Symptomatic, Aggressive, Sporadic, Unresectable, Locally

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Symptomatic, Aggressive, Sporadic, Unresectable, Locally trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedNot Applicable

NCT01945762

Observational Study to Evaluate Vandetanib in RET -/+ Patients With Metastatic Medullary Thyroid Cancer

This is a European multinational, multicenter, non-interventional (observational) and prospective study. It is carried on to confirm in real life conditions the…

Belgium, France +3 more31 participantsStarted 2014-02-17

Treatment: Vandetanib 300 mg